Column Capital Advisors’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$184K Sell
674
-3
-0.4% -$860 0.03% 150
2023
Q2
$207K Sell
677
-14
-2% -$4.04K 0.03% 138
2023
Q1
$197K Buy
691
+80
+13% +$21.2K 0.03% 144
2022
Q4
$149K Hold
611
– – 0.02% 155
2022
Q3
$124K Hold
611
– – 0.03% 164
2022
Q2
$122K Hold
611
– – 0.02% 160
2022
Q1
$163K Sell
611
-39
-6% -$10.1K 0.03% 149
2021
Q4
$174K Sell
650
-11
-2% -$2.89K 0.03% 141
2021
Q3
$174K Sell
661
-7
-1% -$1.87K 0.04% 135
2021
Q2
$174K Hold
668
– – 0.04% 132
2021
Q1
$163K Buy
668
+99
+17% +$23.7K 0.04% 134
2020
Q4
$139K Buy
569
+26
+5% +$5.89K 0.03% 141
2020
Q3
$113K Sell
543
-110
-17% -$21.4K 0.03% 149
2020
Q2
$117K Sell
653
-61
-9% -$11.3K 0.04% 136
2020
Q1
$119K Buy
714
+201
+39% +$39.3K 0.05% 107
2019
Q4
$107K Buy
+513
New +$106K 0.05% 143

Other funds holding SYK

Column Capital Advisors's SYK Position: Q3 2023 in Review

Column Capital Advisors reduced its Stryker (SYK) stake by 0.44% in Q3 2023, selling an estimated $860 and leaving 674 shares worth $184K. The position accounts for 0.03% of the portfolio, ranked #150.

Column Capital Advisors first reported a position in SYK in Q4 2019 and has held it in 16 quarters since. The position peaked at $207K in Q2 2023. 1,772 funds tracked by Wall St. Rank hold SYK as of Q3 2023.

  • Column Capital Advisors held 674 shares of Stryker worth $184K as of Q3 2023.
  • Column Capital Advisors sold 3 Stryker shares in Q3 2023, an estimated $860.
  • Stryker made up 0.03% of Column Capital Advisors's portfolio in Q3 2023, its #150 holding.
  • Column Capital Advisors first reported a position in Stryker in Q4 2019 and has held it in 16 quarters since.
  • Column Capital Advisors's Stryker position peaked at $207K in Q2 2023.
  • 1,772 funds tracked by Wall St. Rank held Stryker as of Q3 2023.

Based on Column Capital Advisors's 13F filing for Q3 2023, filed 3 Nov 2023.